These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38821164)

  • 1. Targeting the interaction of pleiotrophin and VEGFA
    Choleva E; Menounou L; Ntenekou D; Kastana P; Tzoupis Η; Katraki-Pavlou S; Drakopoulou M; Spyropoulos D; Andrikopoulou A; Kanellopoulou V; Enake MK; Beis D; Papadimitriou E
    Eur J Pharmacol; 2024 Aug; 977():176692. PubMed ID: 38821164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotrophin Activates cMet- and mTORC1-Dependent Protein Synthesis through PTPRZ1-The Role of α
    Mourkogianni E; Karavasili K; Xanthopoulos A; Enake MK; Menounou L; Papadimitriou E
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c-Met to up-regulate angiogenesis and lung adenocarcinoma growth.
    Kastana P; Ntenekou D; Mourkogianni E; Enake MK; Xanthopoulos A; Choleva E; Marazioti A; Nikou S; Akwii RG; Papadaki E; Gramage E; Herradón G; Stathopoulos GT; Mikelis CM; Papadimitriou E
    Int J Cancer; 2023 Sep; 153(5):1051-1066. PubMed ID: 37260355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
    Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
    J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.
    Poimenidi E; Theodoropoulou C; Koutsioumpa M; Skondra L; Droggiti E; van den Broek M; Koolwijk P; Papadimitriou E
    Vascul Pharmacol; 2016 May; 80():11-9. PubMed ID: 26924457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
    Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
    Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α
    Lamprou M; Kastana P; Kofina F; Tzoupis Η; Barmpoutsi S; Sajib MS; Koutsioumpa M; Poimenidi E; Zompra AA; Tassopoulos D; Choleva E; Tselios T; Mikelis CM; Papadimitriou E
    Angiogenesis; 2020 Nov; 23(4):621-636. PubMed ID: 32681389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.
    Koutsioumpa M; Poimenidi E; Pantazaka E; Theodoropoulou C; Skoura A; Megalooikonomou V; Kieffer N; Courty J; Mizumoto S; Sugahara K; Papadimitriou E
    Mol Cancer; 2015 Feb; 14(1):19. PubMed ID: 25644401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species.
    Tsirmoula S; Lamprou M; Hatziapostolou M; Kieffer N; Papadimitriou E
    Microvasc Res; 2015 Mar; 98():74-81. PubMed ID: 25582077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta.
    Koutsioumpa M; Hatziapostolou M; Mikelis C; Koolwijk P; Papadimitriou E
    Eur J Pharmacol; 2009 Jan; 602(2-3):245-9. PubMed ID: 19059395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.
    Papadimitriou E; Pantazaka E; Castana P; Tsalios T; Polyzos A; Beis D
    Biochim Biophys Acta; 2016 Dec; 1866(2):252-265. PubMed ID: 27693125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.
    Polytarchou C; Hatziapostolou M; Poimenidi E; Mikelis C; Papadopoulou A; Parthymou A; Papadimitriou E
    Int J Cancer; 2009 Apr; 124(8):1785-93. PubMed ID: 19058221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
    Mikelis C; Sfaelou E; Koutsioumpa M; Kieffer N; Papadimitriou E
    FASEB J; 2009 May; 23(5):1459-69. PubMed ID: 19141530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches.
    Michelotti GA; Tucker A; Swiderska-Syn M; Machado MV; Choi SS; Kruger L; Soderblom E; Thompson JW; Mayer-Salman M; Himburg HA; Moylan CA; Guy CD; Garman KS; Premont RT; Chute JP; Diehl AM
    Gut; 2016 Apr; 65(4):683-92. PubMed ID: 25596181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.
    Shi Y; Ping YF; Zhou W; He ZC; Chen C; Bian BS; Zhang L; Chen L; Lan X; Zhang XC; Zhou K; Liu Q; Long H; Fu TW; Zhang XN; Cao MF; Huang Z; Fang X; Wang X; Feng H; Yao XH; Yu SC; Cui YH; Zhang X; Rich JN; Bao S; Bian XW
    Nat Commun; 2017 Jun; 8():15080. PubMed ID: 28569747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of glioblastoma migration and growth by two forms of pleiotrophin.
    Lu KV; Jong KA; Kim GY; Singh J; Dia EQ; Yoshimoto K; Wang MY; Cloughesy TF; Nelson SF; Mischel PS
    J Biol Chem; 2005 Jul; 280(29):26953-64. PubMed ID: 15908427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki.
    Lecht S; Chiaverelli RA; Gerstenhaber J; Calvete JJ; Lazarovici P; Casewell NR; Harrison R; Lelkes PI; Marcinkiewicz C
    Biochim Biophys Acta; 2015 Jun; 1850(6):1169-79. PubMed ID: 25665484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.